The DOI matches its Crossref record; 153 of the 159 references it cites were found in a registry or an index.
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability
Abstract
Background A meta-analysis of the efficacy and tolerability of selective serotonin reuptake inhibitors (SSRIs) against tricyclic antidepressants (TCAs) in depressed patients was carried out. Methods Efficacy data from 102 randomised controlled trials (10706 patients) were pooled to provide a summary variance-weighted effect size. Tolerability data from 95 studies (10553 patients) were combined to give variance-weighted relative risk of drop out for all reasons and for adverse effects from each study. The effect of age, treatment setting, severity and TCA dose were examined as well as the performance of individual SSRIs and TCAs where there were sufficient studies. Results There is no overall difference in efficacy between SSRIs and TCAs (effect size -0.03, 95% confidence interval -0.09 to 0.03). TCAs do appear more effective in in-patients (-0.23, -0.40 to -0.05) and amitriptyline is more effective than SSRI comparators (-0.14, -0.25 to -0.03) but publication bias cannot be excluded. The SSRIs are better tolerated, with significantly lower rates of treatment discontinuations overall (relative risk 0.88, 0.83 to 0.93; number needed to treat 26) and due to side effects (0.73, 0.67 to 0.80; number needed to treat 33). Individual SSRIs show a similar advantage except for fluvoxamine which does not differ from the TCAs. Individual TCAs show a similar disadvantage in tolerability compared to SSRIs except for dothiepin against which SSRI treatment results in more side-effect related…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, studies have found that between 27 and 31% of patients taking antidepressant medication discontinue treatment because of side effects (Anderson, 2000; MacGillivray et al., 2003).”
From A mindful yoga intervention for young women with major depressive disorder: Design and baseline sample characteristics of a randomized controlled trial (2020) · cites this paper as Anderson, 2000
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Wasserman, S. S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,377
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946
Diagnostic criteria for use in psychiatric research.
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G., & Munoz, R. A. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750190059011 · Cited by 5,491
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,840
Spitzer, R. L., Endicott, J., & Robins, E. (1978) · PsycTESTS Dataset · doi:10.1037/t04137-000 · Cited by 556
Recognition and management of depression in general practice: consensus statement
Paykel, E. S., & Priest, R. G. (1992) · BMJ · doi:10.1136/bmj.305.6863.1198 · Cited by 540
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399
Danish University Antidepressant Group (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90081-i · Cited by 398
Binding of antidepressants to human brain receptors: focus on newer generation compounds
Cusack, B. M., Nelson, A. N., & Richelson, E. (1994) · Psychopharmacology · doi:10.1007/bf02244985 · Cited by 349
Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.
Cohn, C. K., Shrivastava, R., Mendels, J., Cohn, J. B., Fabre, L. F., Claghorn, J. L., Dessain, E. C., Itil, T. M., & Lautin, A. (1990) · PubMed · Cited by 348
Gøtzsche, P. C. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90017-2 · Cited by 339
Anderson, I. M., & Tomenson, B. (1995) · BMJ · doi:10.1136/bmj.310.6992.1433 · Cited by 307
Self-citationCitalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study
Gram, L. F. (1986) · Psychopharmacology · doi:10.1007/bf00172884 · Cited by 301
Relative mortality from overdose of antidepressants
Henry, J. A., Alexander, C., & Sener, E. K. (1995) · BMJ · doi:10.1136/bmj.310.6974.221 · Cited by 290
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+ · Cited by 278
Self-citationReimherr, F. W., Chouinard, G., Cohn, C. K., Cole, J. O., Itil, T. M., LaPierre, Y. D., Masco, H. L., & MENDELS, J. (1990) · PubMed · Cited by 263
A Comparison of Fluoxetine Imipramine and Placebo in Patients with Bipolar Depressive Disorder
Cohn, J. B., COLLINS, G., ASHBROOK, E., & Wernicke, J. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198910000-00006 · Cited by 256
Selective serotonin reuptake inhibitors
Montgomery, S. A., Henry, J. A., McDonald, G. J., Dinan, T. G., LADER, M. H., Hindmarch, I., Clare, A. W., & Nutt, D. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400910-00008 · Cited by 254
Rush, A. J. (1993) · Medical Entomology and Zoology · Cited by 250
Anderson, I. M., & Tomenson, B. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800407 · Cited by 249
Self-citationStark, P., & Hardison, C. D. (1985) · PubMed · Cited by 239
Hg, R. (1992) · PubMed · Cited by 223
A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients
Dunbar, G. C., Cohn, J. B., Fabre, L. F., Feighner, J. P., Fieve, R. R., MENDELS, J., & Shrivastava, R. K. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.159.3.394 · Cited by 172
Feighner, J. P., & Cohn, J. B. (1985) · PubMed · Cited by 170
Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
Grimsley, S. R., & Jann, M. W. (1992) · PubMed · Cited by 163
Antidepressant Prescribing Practices of Outpatient Psychiatrists
Olfson, M., Marcus, S. C., Pincus, H. A., ZITO, J. M., Thompson, J. W., & Zarin, D. A. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.4.310 · Cited by 161
Chouinard, G. (1985) · PubMed · Cited by 157
Hotopf, M. H., Hardy, R., & Lewis, G. (1997) · The British Journal of Psychiatry · doi:10.1192/bjp.170.2.120 · Cited by 142
Comparative Efficacy of Antidepressants
Kasper, S. F., Fuger, J., & Möller, H. ‐. (1992) · Drugs · doi:10.2165/00003495-199200432-00004 · Cited by 139
Fluvoxamine and clomipramine in depressed patients A DOUBLE‐BLIND CLINICAL STUDY
Klok, C. J., Brouwer, G., van Praag, H. M., & Doogan, D. P. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00756.x · Cited by 137
The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis
Mittmann, N., Herrmann, N., Einarson, T. R., Busto, U. E., Lanctôt, K. L., Liu, B. A., Shulman, K. I., Silver, I., Naranjo, C. A., & Shear, N. H. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00107-9 · Cited by 135
A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
Jb, C., & Wilcox, C. M. (1985) · PubMed · Cited by 133
Are SSRIs a Cost-Effective Alternative to Tricyclics?
Hotopf, M. H., Lewis, G., & Normand, C. E. M. (1996) · The British Journal of Psychiatry · doi:10.1192/bjp.168.4.404 · Cited by 104
Dl, D., Jb, C., Walshe, T., Ck, C., Feighner, J. P., Rr, F., Jp, H., Jt, H., Ed, H., & Settle, E. C. (1992) · PubMed · Cited by 89
Donoghue, J., Tylee, A. T., & Wildgust, H. J. (1996) · BMJ · doi:10.1136/bmj.313.7061.861 · Cited by 88
Controlled Trial of Amitriptyline in General Practice
Blashki, T. G., Mowbray, R. M., & Davies, B. (1971) · BMJ · doi:10.1136/bmj.1.5741.133 · Cited by 86
Martin, R. M., Hilton, S. R., Kerry, S., & Richards, N. (1997) · BMJ · doi:10.1136/bmj.314.7081.646 · Cited by 84
Paroxetine in the treatment of depression ‐ a randomized comparison with amitriptyline
Laursen, A. L., Mikkelsen, P. L., Rasmussen, S., & Honoré, P. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb01281.x · Cited by 83
Chronobiology and Psychiatric Disorders
Halaris, A. E. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198901000-00014 · Cited by 80
Itil, T. M., Rk, S., Mukherjee, S., Coleman, B., & Michael, S. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02134.x · Cited by 80
A Placebo-controlled Inpatient Comparison of Fluvoxamine Maleate and Imipramine in Major Depression
Feighner, J. P., Boyer, W. F., Meredith, C. H., & HENDRICKSON, G. G. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198907000-00006 · Cited by 79
Fluvoxamine and chlorimipramine in endogenous depression
Wilde, J. E. M. D., & Doogan, D. P. (1982) · Journal of Affective Disorders · doi:10.1016/0165-0327(82)90009-x · Cited by 77
A double‐blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients
Guillibert, E., Pélicier, Y., Archambault, J. C., Chabannes, J.-P., Cierc, G., Desvilles, M., Guibert, M., Pagot, R., Poisat, J. L., & Thobie, Y. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07192.x · Cited by 75
Montgomery, S., Bebbington, P., Cowen, P. J., Deakin, J. F. W., FREELING, P., Hallström, C., Katona, C., King, D., Leonard, B. E., Levine, S., et al. (1993) · Journal of Psychopharmacology · doi:10.1177/0269881193007001041 · Cited by 72
Fluoxetine in depressed patients: a comparison with imipramine.
Bremner, J. D. (1984) · PubMed · Cited by 70
A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
Feighner, J. P. (1985) · PubMed · Cited by 70
Fluvoxamine in the Treatment of the Older Depressed Patient; Double-blind, Placebo-controlled Data
Wakelin, J. S. (1986) · International Clinical Psychopharmacology · doi:10.1097/00004850-198607000-00005 · Cited by 69
Ravindran, A. V., Judge, R., Hunter, B. N., Bray, J., Morton, N. H., & The Paroxetine Study Group (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0305 · Cited by 67
A double‐blind controlled clinical trial comparing fluvoxamine with imipramine.
Guelfi, J., Dreyfus, J. F., & Pichot, P. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02131.x · Cited by 67
A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
Dominguez, R. A., Goldstein, B. J., Jacobson, A. F., & Steinbook, R. M. (1985) · PubMed · Cited by 65
Fluoxetine and Desipramine in Major Depressive Disorder
Bowden, C. L., Schatzberg, A. F., ROSENBAUM, A., Contreras, S. A., SAMSON, J. A., Dessain, E. C., & Sayler, M. E. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199310000-00002 · Cited by 64
A Multicenter Double-Blind Trial of Paroxetine Versus Amitriptyline in Depressed Inpatients
Stuppaeck, C., Geretsegger, C., Whitworth, A. B., SCHUBERT, H., Platz, T., NIG, P. K., Hinterhuber, H., & Fleischhacker, W. W. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199408000-00003 · Cited by 64
Fairweather, D. B., Kerr, J., Harrison, D. A., Moon, C. A. L., & Hindmarch, I. (1993) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470080108 · Cited by 63
Comparative effects of fluoxetine and amitriptyline on cardiac function.
Upward, J., Edwards, J. G., Goldie, A., & Waller, D. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03397.x · Cited by 62
Doogan, D. P., & Langdon, C. J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400920-00005 · Cited by 61
Fluoxetine in Major Depression: Efficacy, Safety and Effects on Sleep Polygraphic Variables
KERKHOFS, M., RIELAERT, C., MAERTELAER, V. D., LINKOWSKI, P., CZARKA, M., & MENDLEWICZ, J. (1990) · International Clinical Psychopharmacology · doi:10.1097/00004850-199010000-00002 · Cited by 61
Treatment of major affective disorder with fluvoxamine.
Lapierre, Y. D., Browne, M., Horn, E., Lk, O., Sarantidis, D., Roberts, N., Badoe, K., & Tessier, P. (1987) · PubMed · Cited by 60
Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing.
de Wilde, J., Mertens, C., & Wakelin, J. S. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02133.x · Cited by 59
A Double-Blind Comparison of Fluoxetine, Imipramine and Placebo in Outpatients with Major Depression
Feighner, J. P., Boyer, W. F., Merideth, C., & HENDRICKSON, G. G. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198904000-00004 · Cited by 58
Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients
Geretsegger, C., Fartacek, R. R., Stuppaeck, C., Mair, M., Platz, T., & Heim, M. (1995) · Psychopharmacology · doi:10.1007/bf02246291 · Cited by 58
Rosenberg, C., Damsbo, N., Fuglum, E., Jacobsen, L. V., & Horsgård, S. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00007 · Cited by 58
Paroxetine in the treatment of melancholia and severe depression
Tignol, J., Stoker, M. J., & Dunbar, G. C. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199211000-00005 · Cited by 57
Kasper, S. F., Voll, G., Vieira, A., & Kick, H. A. (1990) · Pharmacopsychiatry · doi:10.1055/s-2007-1014496 · Cited by 55
Fluvoxamine Maleate in the Treatment of Depression
Claghorn, J. L., Earl, C. Q., Walczak, D. D., Stoner, K. A., Wong, L. F., Kanter, D. R., & Houser, V. P. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199604000-00003 · Cited by 54
A double‐blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder
Mullin, J. M., Vr, P.-G., & Whitehead, A. M. (1988) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1988.tb08510.x · Cited by 54
Thompson, C. M., & Thompson, C. M. (1989) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470040305 · Cited by 53
Severity of depression and response to fluoxetine
Pande, A. C., & Sayler, M. E. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300840-00006 · Cited by 51
Amin, M. M., Ananth, J., Coleman, B. S., DARCOURT, G., Farkas, T., Goldstein, B. J., Lapierre, Y. O., Paykel, E. S., & Wakelin, J. S. (1984) · Clinical Neuropharmacology · doi:10.1097/00002826-198406001-00286 · Cited by 51
A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients
Norton, K., Sireling, L., Bhat, A., Rao, B., & Paykel, E. S. (1984) · Journal of Affective Disorders · doi:10.1016/0165-0327(84)90051-x · Cited by 49
Lymphocyte function in major depression
Altshuler, L. L., Plaeger-Marshall, S., Richeimer, S. H., Daniels, M., & Baxter, L. R. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb01314.x · Cited by 47
Double-Blind Multicenter Study of Paroxetine and Amitriptyline in Depressed Inpatients
Möller, H., Berzewski, H., Eckmann, F., Gonzalves, N., Kissling, W., Knorr, W., Ressler, P. K., Rudolf, G., Steinmeyer, E. M., Magyar, I., et al. (1993) · Pharmacopsychiatry · doi:10.1055/s-2007-1014346 · Cited by 47
Mk, R., Mj, A., Savla, N., Rr, S., Jm, K., & Ashford, J. J. (1991) · PubMed · Cited by 47
TOLLEFSON, G. D., GREIST, J. H., JEFFERSON, J. W., HEILIGENSTEIN, J. H., SAYLER, M. E., TOLLEFSON, S. L., & KOBACK, K. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199412000-00003 · Cited by 47
A Comparison of Fluoxetine and Amitriptyline in the Treatment of Major Depression
Keegan, D. A., Bowen, R., Blackshaw, S. L., SALEH, S., Dayal, N., REMILLARD, F., Shrikhande, S., PEREZ, S. C., Boulton, A. L., RICHARDSON, S., et al. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199100620-00007 · Cited by 46
Citalopram versus maprotiline: A controlled, clinical multicentre trial in depressed patients
Bouchard, J. M., Delaunay, J., Delisle, J. ‐., Grasset, N., Mermberg, P. F., Molczadzki, M., Pagot, R., Richou, H., Robert, G., Ropert, R., et al. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02923.x · Cited by 46
Lydiard, R. B., Laird, L. K., Morton, W. A., Steele, T. E., Kellner, C. H., Mt, L., & Jc, B. (1989) · PubMed · Cited by 46
Fluoxetine vs Amitriptyline in the Treatment of Depressed Out-patients
Laakmann, G., Blaschke, D., Engel, R. R., & Schwarz, A. (1988) · The British Journal of Psychiatry · doi:10.1192/s0007125000297316 · Cited by 44
March, J. S., Kobak, K. A., Jefferson, J. W., Mazza, J., & Greist, J. H. (1990) · PubMed · Cited by 44
The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
Rs, N., Perel, J. M., Pollock, B. G., & Dj, K. (1990) · PubMed · Cited by 44
Recognition and management of narcolepsy
Stores, G. (1999) · Archives of Disease in Childhood · doi:10.1136/adc.81.6.519 · Cited by 43
A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression
Roth, D. A., Mattes, J. A., Sheehan, K. H., & Sheehan, D. V. (1990) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(90)90078-u · Cited by 43
A Controlled Comparison of Fluoxetine and Amitriptyline in Depressed Out-patients
Young, J. P. R., Coleman, A., & Lader, M. H. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.151.3.337 · Cited by 42
A Double-Blind Multicentre Study of Paroxetine and Amitriptyline in Depressed Outpatients
Bignamini, A., & Rapisarda, V. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199206004-00008 · Cited by 42
A double‐blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine.
DICK, P. H., & Ferrero, E. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02132.x · Cited by 42
A Comparative Trial of a New Antidepressant, Fluoxetine
Levine, S., Deo, R., & Mahadevan, K. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.150.5.653 · Cited by 41
A double‐blind comparison of citalopram (Lu 10–171) and amitriptyline in depressed patients
Gravem, A., Amthor, K.-F., Astrup, C., Elgen, K., GJESSING, L. R., Gunby, B., Pettersen, R., Kyrdalen, L., Vaadal, J., Øfsti, E., et al. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02821.x · Cited by 41
Fluvoxamine. A review of its safety profile in world-wide studies
Wagner, W., Zaborny, B. A., & Gray, T. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400940-00001 · Cited by 40
A Comparison of the Antidepressant Action of Citalopram and Amitriptyline
Shaw, D., Thomas, D. R., Briscoe, M. H., Crimmins, R., Harris, B., Lovett, J., Raj, M., Lloyd, A. T., Osborne, C., Hughes, G., et al. (1986) · The British Journal of Psychiatry · doi:10.1192/bjp.149.4.515 · Cited by 40
Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice
Øhrberg, S., Christiansen, P. E., Severin, B., Calberg, H., Nilakantan, B., Borup, A., Søgaard, J., Larsen, S. B., Loldrup, D., Bahr, B., et al. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03294.x · Cited by 40
CORNE, S. J., & HALL, J. R. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198907000-00007 · Cited by 39
The efficacy of fluvoxamine in patients with severe depression
Ottevanger, E. A. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90080-9 · Cited by 39
Heiligenstein, J. H., Tollefson, G. D., & Faries, D. E. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300840-00007 · Cited by 38
Fluvoxamine and imipramine in the treatment of depressive patients: A double-blind controlled study
Gonella, G., Baignoli, G., & Ecari, U. (1990) · Current Medical Research and Opinion · doi:10.1185/03007999009111499 · Cited by 38
Timmerman, L., de Beurs, P., TAN, B. K., Leijnse-Ybema, H. J., Sánchez, C., Petersen, H. E. H., & Stuart, M. (1987) · International Clinical Psychopharmacology · doi:10.1097/00004850-198707000-00006 · Cited by 38
Lf, F., Mb, S., & Tm, I. (1991) · PubMed · Cited by 38
Fluoxetine Efficacy vs Comparative Drugs: An Overview
LADER, M. H. (1988) · The British Journal of Psychiatry · doi:10.1192/s0007125000297298 · Cited by 37
Moon, C. A. L., Jago, W., Wood, K., & Doogan, D. P. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800306 · Cited by 37
A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression
de Jonghe, F., Ravelli, D. P., & Tuynman-Qua, H. G. (1991) · Pharmacopsychiatry · doi:10.1055/s-2007-1014440 · Cited by 36
Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients
Fabre, L., Birkhimer, L. J., Zaborny, B. A., Wong, L. F., & Kapik, B. M. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606000-00006 · Cited by 36
Dunbar, G. C. (2008) · Pharmacology · doi:10.1159/000139327 · Cited by 35
Paroxetine and amitriptyline in the treatment of depression in general practice
Christiansen, P. E., Behnke, K., Black, C. H., Öhrström, J. K., Bork‐Rasmussen, H., & Nilsson, J.-E. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb10623.x · Cited by 33
A double‐blind study of the comparative antidepressant effect of paroxetine and amitriptyline
Kuhs, H., & Rudolf, G. A. E. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07198.x · Cited by 32
Nielsen, B. M., Behnke, K., Arup, P., Christiansen, P. E., Geisler, A. E., Ipsen, E. Ø., Maach‐Møller, B., & Øhrberg, S. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03370.x · Cited by 32
Battegay, R., Hager, M., & Rauchfleisch, U. (2008) · Neuropsychobiology · doi:10.1159/000118159 · Cited by 32
Fluoxetine versus amitriptyline in the treatment of major depression
Beasley, C. M., Sayler, M. E., & Potvin, J. H. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00002 · Cited by 31
The impact of sertraline, desipramine, and placebo on psychomotor functioning in depression
Ravindran, A. V., Teehan, M. D., Bakish, D., Yatham, L. N., O’Reilly, R., Fernando, M. L. D., Manchanda, R., Charbonneau, Y., & Buttars, J. A. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100404 · Cited by 31
Randomized Double-Blind Study of Fluvoxamine and Maprotiline in Treatment of Depression
de Jonghe, F., Swinkels, J. A., & Tuynman-Qua, H. G. (1991) · Pharmacopsychiatry · doi:10.1055/s-2007-1014428 · Cited by 31
Effect size of efficacy measures comparing divalproex, lithium and placebo in acute mania
Bowden, C. L., Davis, J. M., Morris, D. D., Swann, A. C., Calabrese, J. R., Lambert, M., & Goodnick, P. J. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)6:1 · Cited by 31
A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness
Robertson, M. M., Abou‐Saleh, M. T., Harrison, D. A., Nairac, B. L., Edwards, D. R. L., Lock, T., Burns, R. A., & Katona, C. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800205 · Cited by 31
Moon, C., & Vince, M. (1996) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1996.tb09542.x · Cited by 30
Arminen, S.-L., Ikonen, U., Pulkkinen, P., Leinonen, E. V. J., Mahlanen, A., Koponen, H., Kourula, K., Ryyppö, J., Korpela, V., Lehtonen, M. L., et al. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01533.x · Cited by 30
Bascara, L. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07196.x · Cited by 28
A double‐blind clinical trial of fluvoxamine and imipramine in patients with primary depression
Guy, W., Wilson, W. H., Ban, T. A., King, D. L., Manov, G., & Fjetland, O. K. (1984) · Drug Development Research · doi:10.1002/ddr.430040203 · Cited by 28
Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptiline.
Altamura, A. C., Percudani, M., Guercetti, G., & INVERNIZZI, G. (1989) · PubMed · Cited by 27
Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial
Noguera, R., Altuna, R., Álvarez, E., Ayuso, J. L., Casais, L., & Udina, C. (1991) · Journal of Affective Disorders · doi:10.1016/0165-0327(91)90045-t · Cited by 27
Gagiano, C. A., Muller, P. G. M., Fourie, J., & Roux, J. F. L. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07191.x · Cited by 27
Judd, F. K., Moore, K., Norman, T. R., Burrows, G. D., Gupta, R. K., & Parker, G. (1993) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679309072123 · Cited by 25
Nielsen, O. A., Morsing, I., Petersen, J. S., Larsen, T., Møller, S. E., Manniche, P. M., Skausig, O. B., Bille, N., Fredslund‐Andersen, F., Jensen, E., et al. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb03136.x · Cited by 24
Fluoxetine versus clomipramine in major depressive disorders.
Ropert, R. (1989) · PubMed · Cited by 24
Ottevanger, E. A. (1995) · PubMed · Cited by 23
Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
Poelinger, W., & Haber, H. L. (1989) · PubMed · Cited by 22
Double-blind comparison of fluvoxamine and imipramine in depressed patients
Amore, M., Bellini, M., Berardi, D., Berlinzani, L., Cerviño, G., Cremonini, A., Ferrari, G. R. A., & Innamorati, A. (1989) · CINECA IRIS Institutial Research Information System (University of Genoa) · Cited by 22
Are in‐patient depressives more often of the melancholic subtype?
Stage, K. B., Bech, P., Gram, L. F., Kragh-Sørensen, P., Rosenberg, C., & Øhrberg, S. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10115.x · Cited by 22
Stott, P., Blagden, M. D., & Aitken, C. A. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90100-z · Cited by 21
A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
Guy, W., Wh, W., Ban, T. A., King, D. L., Manov, G., & Ok, F. (1984) · PubMed · Cited by 21
Bersani, G., Rapisarda, V., Ciani, N., Bertolino, A., & Sorge, G. (1994) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470090108 · Cited by 21
Pélicier, Y., & Schaeffer, P. (1994) · PubMed · Cited by 20
Meta‐analysis of early phase I1 studies with paroxetine in hospitalized depressed patients
Byrne, M. M. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07194.x · Cited by 20
Perspectives in Clinical Psychopharmacology of Amitriptyline and Fluvoxamine
Gasperini, M., Gatti, F., Bellini, L., Anniverno, R., & Smeraldi, E. (2008) · Neuropsychobiology · doi:10.1159/000118918 · Cited by 20
A Double-blind Multi-centre Trial of Fluoxetine and Dothiepin in Major Depressive Illness
SOUTH WALES ANTIDEPRESSANT DRUG TRIAL GROUP (1988) · International Clinical Psychopharmacology · doi:10.1097/00004850-198801000-00006 · Cited by 18
A double-blind study of fluoxetine and imipramine in major depression.
Bressa, G. M., Brugnoli, R., & Pancheri, P. (1989) · PubMed · Cited by 18
An Italian multicenter experience with fluvoxamine, a new antidepressant drug, versus imipramine
Bramanti, P., Ricci, R. M., Roncari, R., Bilone, F., Inga, F., Teti, V., Cristofaro, A. M. D., Ceccarelli, G., Perri, R. D., & Candela, L. (1988) · Current Therapeutic Research · Cited by 17
An Overview of Paroxetine in the Elderly
Dünner, D. L. (2009) · Gerontology · doi:10.1159/000213617 · Cited by 17
Comparison of fluoxetine and desipramine in depressed outpatients
Remick, R. A., Claman, J., Reesal, R. T., Gibson, R. E., Agbayewa, M. O., Lam, R. W. M., & Keller, F.-E. (1993) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80653-8 · Cited by 17
Comparison of fluvoxamine and amitriptyline in depressed outpatients
Remick, R. A., Reesal, R. T., Oakander, M. A., Allen, J., Claman, J., Ramirez, C. E., Perry, K., & Keller, F.-E. (1994) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80168-7 · Cited by 17
Tamminen, T., & Vv, L. (1989) · PubMed · Cited by 16
Loeb, C., Albano, C., & Gandolfo, C. (1989) · PubMed · Cited by 16
The importance of accidents in evaluating the cost of SSRIs
Hale, A. S. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199409000-00008 · Cited by 16
Fontaine, R. (1991) · European Neuropsychopharmacology · doi:10.1016/0924-977x(91)90658-h · Cited by 15
The place of obsessive compulsive disorder in the diagnostic hierarchy
Montgomery, S. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199206001-00005 · Cited by 14
Manna, V., Martucci, N., & AGNOLI, A. (1989) · PubMed · Cited by 14
The efficacy of fluoxetine versus maprotiline in depressed patients and by dose
Kuha, S., Mehtonen, O. ‐., Henttonen, A., & Naarala, M. (1991) · Nordic Journal of Psychiatry · doi:10.3109/08039489109103274 · Cited by 14
The efficacy of fluvoxamine in patients with severe depression
Ottevanger, E. A. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199202001-00665 · Cited by 13
Pakesch, G., & Dossenbach, M. R. K. (1991) · PubMed · Cited by 12
Secondary and Meta-Analysis of the Efficacy of Non-Tricyclic Antidepressants
Möller, H., & Haug, G. (1988) · Pharmacopsychiatry · doi:10.1055/s-2007-1017009 · Cited by 11
β2-Adrenoceptor antagonism in anxiety
Cooper, S. J., Kelly, C., McGilloway, S., & Gilliland, A. E. (1990) · European Neuropsychopharmacology · doi:10.1016/0924-977x(90)90016-4 · Cited by 10
Treatment of severe major depression: A double-blind study of sertraline and clomipramine
Lépine, J., & Wiseman, R. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)87872-2 · Cited by 7
McEntee, W. J., Ko, G., & Richter, E. M. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)87466-9 · Cited by 7
Arminen, S.-L., Ikonen, U., Pulkkinen, M., Leinonen, E. V. J., Mahlanen, A., Koponen, H., Kourula, K., Ryyppö, J., Korpela, V., Lehtonen, M., et al. (1992) · Nordic Journal of Psychiatry · doi:10.3109/08039489209101158 · Cited by 6
Renal disease and acid-suppressing drugs
Rodriguez, L. A. G., Wallander, M.-A. A., Johanson, S., & Björck, S. (1997) · Pharmacoepidemiology and Drug Safety · doi:10.1002/(sici)1099-1557(199707)6:4 · Cited by 3
Research works printed but not linked: 14
- Amin, 1984, Fluvoxamine: antidepressant effects confirmed in a placebo-controlled international study, Clin. Neuropharmacol., 7, S316
- Anderson, 1998, A meta-analysis of controlled trials comparing SSRIs in the treatment of depression, J. Psychopharmacol., 12, A20
- Dowling, 1990, Fluoxetine: a comparative study with dothiepin, Irish J. Psychiatry, Spring, 3
- 1993, The treatment of depression in primary care, Effective Health Care Bull., 5, 1
- Fawcett, 1989, Fluoxetine versus amitriptyline in adult out-patients with major depression, Curr. Ther. Res., 45, 821
- Ginestet, 1989, Fluoxetine in endogenous depression melancholia versus clomipramine, Int. Clin. Psychopharmacol., 4, 37
- Harris, 1991, Fluvoxamine versus amitriptyline in depressed hospital out-patients: A multicentre double-blind comparative trial, Br. J. Clin. Res., 2, 89
- Hutchinson, 1991, A double blind study in general practice to compare the efficacy and tolerability of paroxetine and amitriptyline in depressed elderly patients, Br. J. Clin. Res., 2, 43
- Masco, 1985, Double-blind comparison of fluoxetine and amitriptyline in the treatment of major depressive illness, Adv. Ther., 2, 275
- Pakesch, 1991, Depressive syndrome in a clinical trial with private practitioners. [German] OT – Wirkung und Sicherheit von Fluoxetin versus Clomipramin bei ambulanten Patienten mit einem depressiven Syndrom in einer klinischen Prufung bei niedergelassenen Arzten, Wien. Klin. Wochenschr., 103, 176
- Pélicier, 1993, Etude multicentrique en double aveugle comparant l’efficacité et la tolerance de la paroxetine et de la clomipramine dans la dépression réactionnelle du sujet âgé, L’Encéphale, XIX, 257
- Peters, 1990, Therapy of depression in the psychiatrist’s office – A double-blind multicenter study, Nervenheilkunde, 9, 28
- Remick, 1989, A comparison between fluoxetine and doxepin in depressed patients, Curr. Ther. Res., 46, 842
- Taneri, 1989, Fluoxetine versus nomifensine in out-patients with neurotic or reactive depression disorder, Int. Clin. Psychopharmacol., 4, 56
Cited by
Sorted by citations
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,372
Anderson, I. M., Ferrier, I. N., Baldwin, R., Cowen, P. J., Howard, L. M., Lewis, G., Matthews, K., McAllister-Williams, H., Peveler, R. C., Scott, J. L., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 909
Self-citationMalhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“Lithium, a widely supported and used augmentation agent, is found to be more effective than placebo in augmentation of TCAs, SSRIs and other antidepressants (Bauer et al., 2000; Crossley and Bauer, 2007).”
BackgroundInfluentialCleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Self-citationBymaster, F. P. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00298-6 · Cited by 725
Metadata
- Authors
- Anderson, I. M.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Anderson, Ian M.
- ORCID
- Anderson, Ian M.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2000-04
- Volume
- 58
- Issue
- 1
- Pages
- 19-36
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2101963851
- Cited by
- 940
- References
- 159
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 29 · 2023: 22 · 2022: 19 · 2021: 13 · 2020: 175 · 2019: 18 · 2018: 26 · 2017: 34 · 2016: 23 · 2015: 35 · 2014: 44 · 2013: 36 · 2012: 52
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Affective Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- selective serotonin reuptake inhibitors, tricyclic antidepressants, depression, antidepressant efficacy, antidepressant tolerability, treatment discontinuation, adverse drug reactions, amitriptyline, fluvoxamine, dothiepin, inpatient care, publication bias
- MeSH terms
- Antidepressive Agents, Tricyclic, Depressive Disorder, Humans, Randomized Controlled Trials as Topic, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review